Juno Therapeutics Lands $265,000,000 New Financing Round

  • Feed Type
  • Date
    12/19/2014
  • Company Name
    Juno Therapeutics
  • Mailing Address
    307 Westlake Avenue North Seattle, WA 98109 USA
  • Company Description
    Juno (NASDAQ: JUNO) is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies.
  • Website
    http://www.junotherapeutics.com
  • Transaction Type
    IPO
  • Transaction Amount
    $265,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are included with company statements at the SEC.
  • M&A Terms